• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
WHI-P131

WHI-P131

Product ID W2933
Cas No. 202475-60-3
Purity ≥99%
Product Unit SizeCostQuantityStock
50 mg $146.10 In stock
250 mg $640.10 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

WHI-P131 is an inhibitor of JAK3 and EGFR that exhibits anticancer chemotherapeutic, chemopreventive, anti-inflammatory, and anti-diabetic properties. WHI-P131 is prophylactic against carcinogenesis induced by UVB exposure in vivo, delaying lesion appearance and decreasing lesion volume and number. WHI-P131 decreases plasma creatine kinase and lactate dehydrogenase activity, decreasing infarct size, myocardial apoptosis and deterioration, and inflammation in animal models of ischemia. Additionally, WHI-P131 decreases TNF-α-induced expression of ICAM-1, VCAM-1, and fractalkine, improving myocardial permeability in cellular models. WHI-P131 displays potential as a prophylactic treatment for diabetes, as its inhibition of JAK3 and suppression of NF-κB results in decreased production of NO and iNOS, preventing destruction of pancreatic islet cells.

Product Info

Cas No.

202475-60-3

Purity

≥99%

Formula

C16H15N3O3 • HCl

Formula Wt.

333.77

Chemical Name

4-[(4’-hydroxyphenyl)amino]-6,7-dimethoxyquinazoline

IUPAC Name

4-[(6,7-dimethoxyquinazolin-4-yl)amino]phenol

Synonym

JANEX-1

Solubility

DMSO (25mg/ml)

Appearance

Yellow Powder

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

W2933 MSDS PDF

Info Sheet

W2933 Info Sheet PDF

Brochures

JAK/STAT Flyer

References

Oh YB, Ahn M, Lee SM, et al. Inhibition of Janus activated kinase-3 protects against myocardial ischemia and reperfusion injury in mice. Exp Mol Med. 2013 May 17;45:e23. PMID: 23680658.

Lee JE, Lee AS, Kim DH, et al. Janex-1, a JAK3 inhibitor, ameliorates tumor necrosis factor-α-induced expression of cell adhesion molecules and improves myocardial vascular permeability in endotoxemic mice. Int J Mol Med. 2012 May;29(5):864-70. PMID: 22344597

Uckun FM, Dibirdik I, Qazi S. Prevention of UVB-induced skin inflammation, genotoxicity, and photocarcinogenesis in mice by WHI-P131, a dual-function inhibitor of Janus kinase 3 and EGF receptor kinase. Arzneimittelforschung. 2010;60(4):218-25. PMID: 20486473

Lv N, Kim EK, Song MY, et al. JANEX-1, a JAK3 inhibitor, protects pancreatic islets from cytokine toxicity through downregulation of NF-kappaB activation and the JAK/STAT pathway. Exp Cell Res. 2009 Jul 15;315(12):2064-71. PMID: 19414010

Linwong W, Hirasawa N, Aoyama S, et al. Inhibition of the antigen-induced activation of rodent mast cells by putative Janus kinase 3 inhibitors WHI-P131 and WHI-P154 in a Janus kinase 3-independent manner. Br J Pharmacol. 2005 Jul;145(6):818-28. PMID: 15852029.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • C9613

    Cyclosporin D

    Cyclosporin metabolite; weak calmodulin inhibit...

    ≥98%
  • T0108

    10-Deacetyl-7-xylosyltaxol

    Taxane found in species of Taxus; potential mic...

    ≥98%
  • R2714

    Recombinant HCV-NS5 Antigens

    Recombinant HCV antigen fragment.

    ≥95%
  • B5000

    BMS-911543

    JAK2 inhibitor.

    ≥99%
  • U6860

    Urocortin III, mouse

    Endogenous peptide, involved in stress signalin...

    ≥95%
  • L0209

    Lactoferrin, cow

    Endogenous glycoprotein; lactoferrin agonist.

    ≥92%
  • R1626

    Regorafenib Monohydrate

    VEGFR1/2/3, TIE2, PDGFRβ, FGFR1, c-Kit, RET, B...

    ≥99%
  • D1643

    Delta Sleep Inducing Peptide

    Peptide; GABA potentiator, NMDA negative allost...

    ≥95%
  • S6131

    N,N-Dimethyl-Sphingosine

    PP2A activator, Sphk1 and PKC inhibitor.

    ≥98%
  • C002045

    Oxazolidine Cabazitaxel

    Synthesis impurity

    ≥95%
  • T3310

    Ticlopidine Hydrochloride

    Thienopyridine; P2Y12 antagonist.

    ≥98%
  • C8017

    Cuelure

    Hormonal attractant for male Bactrocera flies.<...

    ≥97%
  • A4534

    Aliskiren Hemifumarate

    Renin inhibitor.

    ≥98%
  • E2542

    Met-Enkephalin Amide

    Endogenous opioid peptide; δOR and μOR agonis...

    ≥95%
  • P7219

    Pseudolaric Acid B

    Diterpene acid found in Pseudolarix kaempferi.<...

    ≥98%
  • A2048

    Aflatoxin G1

    Mycotoxin produced by species of Aspergillus; D...

    ≥98%
  • I7558

    1-Isothiocyanato-9-(methylsulfenyl)-nonane

    ITC, erucin analog.

    ≥97%
  • V1810

    Vecuronium Bromide

    Non-depolarizing NMJ blocker; nAChR antagonist....

    ≥98%
  • G7241

    GSK-461364

    PLK1 inhibitor.

    ≥99%
  • A4924

    AMG-208

    c-MET and Ron inhibitor.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only